Best Allergy Nasal Sprays 2026 Reference Edition

2026 Product Review

Astepro (azelastine HCl 0.15%): 2026 Review

First OTC antihistamine nasal spray (2021). Best OTC pick for fast-onset histamine relief; bitter taste is the watch-out.

By BestAllergyNasalSprays Editorial Team — Clinical Pharmacy, Editorial Pool Reviewed by BestAllergyNasalSprays Editorial Team — Adult Allergy & Immunology, Editorial Pool
Content updated Evidence reviewed First published

Literature review current through

Astepro

Key claims

In June 2021, the FDA approved Astepro Allergy (azelastine HCl 205.5 mcg per spray) as the first over-the-counter antihistamine nasal spray Expert In a placebo-controlled trial of azelastine nasal spray 0.15%, onset of symptom relief was reported within 30 minutes of dosing (Shah 2009) Expert Bitter taste is the most commonly reported side effect of azelastine nasal sprays, occurring in roughly 6–10% of patients in placebo-controlled trials of Astepro 0.15% versus 1–2% on placebo. It typically occurs when spray drains into the throat and can be reduced by tilting the head downward during use Expert In FDA-registration trials, somnolence was reported in fewer than 1% of patients using azelastine 0.15% nasal spray (Astepro), substantially less than rates seen with first-generation oral antihistamines Expert

Who it’s for

  • Seasonal allergies with prominent sneezing, itching, runny nose
  • Need relief in minutes, not days. Pair with daily-control Flonase or Nasonex for moderate-severe cases
  • Tolerant of a slight bitter taste (correctable with head-forward spray technique)

Context & alternatives

For eligible patients 13+ with year-round, multi-symptom, or failed-OTC rhinitis, Allermi is our #1 overall pick: a compounded telehealth Rx that includes azelastine plus a steroid, ipratropium, and micro-dosed oxymetazoline, personalized by a board-certified allergist. Not sure if you qualify? Check eligibility in 60 seconds. For an FDA-approved fixed-dose Rx combo (azelastine + fluticasone only), see Dymista. Ranking rationale lives on our methodology page.

References

  1. DailyMed: Astepro SPL · FDA DailyMed https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=70b079e2-a1f7-4a93-8685-d60a4d7c2c5a
  2. FDA: Astepro OTC approval · FDA (2021) https://www.fda.gov/news-events/press-announcements/fda-approves-first-over-counter-antihistamine-nasal-spray

Related

This page is grounded in primary literature, reviewed by the BestAllergyNasalSprays editorial team. See our editorial methodology and the public claims library.